🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a pivotal, randomized, double-blind, placebo-controlled trial eval...
Status
Terminated
Location
University Of Alabama
Start Date
2020-07-07
Trial ID
NCT04181762
Treatments Being Tested
This study was designed to evaluate the efficacy and safety of secukinumab ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-01-30
Trial ID
NCT03765788
Treatments Being Tested
This was a randomized, double-blind, active controlled, multicenter, parall...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-04-03
Trial ID
NCT02745080
Treatments Being Tested
This study will assess the efficacy and safety of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-09-29
Trial ID
NCT02267135
Treatments Being Tested
The purpose of this study was to demonstrate efficacy, including effects on...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-08-30
Trial ID
NCT02771210
Treatments Being Tested
The purpose of the study was to evaluate the efficacy and safety of secukin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-06-30
Trial ID
NCT03136861
Treatments Being Tested
The purpose of this study was to demonstrate the clinical efficacy, safety ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-04-29
Trial ID
NCT02696031
Treatments Being Tested
This study will assess the safety and efficacy of secukinumab compared to p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-06
Trial ID
NCT01365455
Treatments Being Tested
This study evaluated the effect of secukinumab compared to placebo on aorti...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-02-10
Trial ID
NCT02690701
Treatments Being Tested
The study will assess the safety and efficacy of intravenous (10mg/kg) and ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-12
Trial ID
NCT01412944
Treatments Being Tested